Antibody interactions with the capsule of Cryptococcus neoformans

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3642-3650

  Feldmesser, Marta ^a   Rivera, Johanna ^a   Kress, Yvonne ^a   Kozel, Thomas R ^b   Casadevall, Arturo ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANALYTIC METHOD; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; BINDING SITE; CELL SUSPENSION; COMPLEMENT ACTIVATION; CRYPTOCOCCUS NEOFORMANS; ENCAPSULATION; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; BINDING SITES; CELL WALL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; GOLD; IMMUNOGLOBULIN M; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; POLYSACCHARIDES;

EID: 0034034359     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3642-3650.2000     Document Type: Article

References (39)

1. Al-Doory, Y. 1971. The ultrastructure of Cryptococcus neoformans. Sabouraudia 9:113-118.
2. Bolduan, C. F., and J. Koopman. 1917. Immune sera, p. 67-134. John Wiley & Sons, Inc., New York, N.Y.
3. Casadevall, A., M. DeShaw, M. Fan, F. Dromer, T. R. Kozel, and L. Pirofski. 1994. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 62:3864-3872.
4. Casadevall, A., J. Mukherjee, S. J. N. Devi, R. Schneerson, J. B. Robbins, and M. D. Scharff. 1992. Antibodies elicited by a Cryptococcus neoformans glucuronoxylomannan-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J. Infect. Dis. 65:1086-1093.
5. Cassone, A., N. Simonetti, and V. Strippoli. 1974. Wall structure and bud formation on Cryptococcus neoformans. Arch. Microbiol. 95:205-212.
6. Cherniak, R., and J. B. Sundstrom. 1994. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62:1507-1512.
7. Cleare, W., M. E. Brandt, and A. Casadevall. 1999. Monoclonal antibody 13F1 produces annular immunofluorescent patterns on Cryptococcus neoformans serotype AD isolates. J. Clin. Microbiol. 37:3080.
8. Cleare, W., and A. Casadevall. 1998. The different binding patterns of two IgM monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlates with serotype classification and differences in functional assays. Clin. Diagn. Lab. Immunol. 5:125-129.
9. Cleare, W., and A. Casadevall. 1999. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release. Med. Mycol. 37:235-243.
10. Dromer, F., S. Mathoulin, B. Dupont, and A. Laporte. 1996. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). Clin. Infect. Dis. 23:82-90.
11. Dromer, F., J. Salamero, A. Contrepois, C. Carbon, and P. Yeni. 1987. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 55:742-748.
12. Eckert, T. F., and T. R. Kozel. 1987. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 55:1895-1899.
13. Edwards, M. R., M. A. Gordon, E. W. Lapa, and W. C. Ghiorse. 1967. Micromorphology of Cryptococcus neoformans. J. Bacteriol. 94:766-777.
14. Feldmesser, M., and A. Casadevall. 1997. Effect of serum IgG1 against murine pulmonary infection with Cryptococcus neoformans. J. Immunol. 158: 790-799.
15. Feldmesser, M., and A. Casadevall. 1998. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection. Front. Biosci. 3:136-151.
16. Feldmesser, M., A. Casadevall, Y. Kress, G. Spira, and A. Orlofski. 1997. Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro. Infect. Immun. 65:1899-1907.
17. Granger, D. L., J. R. Perfect, and D. T. Durack. 1985. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J. Clin. Investig. 76:508-516.
18. Kozel, T. R. 1996. Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9:34-46.
19. Kozel, T. R., B. C. H. deJong, M. M. Grinsell, R. S. MacGill, and K. K. Wall. 1998. Characterization of anti-capsular monoclonal antibodies that regulate activation of the complement system by Cryptococcus neoformans. Infect. Immun. 66:1538-1546.
20. Levitz, S. M., D. J. DiBenedetto, and R. D. Diamond. 1987. A rapid fluorescent assay to distinguish attached from phagocytized yeast particles. J. Immunol. Methods 101:37-42.
21. Littman, M. L. 1958. Capsule synthesis by Cryptococcus neoformans. Trans. N. Y. Acad. Sci. 20:623-648.
22. Mukherjee, J., A. Casadevall, and M. D. Scharff. 1993. Molecular characterization of the antibody responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J. Exp. Med. 177:1105-1106.
23. Mukherjee, J., G. Nussbaum, M. D. Scharff, and A. Casadevall. 1995. Protective and non-protective monoclonal antibodies to Cryptococcus neoformans originating from one B-cell. J. Exp. Med. 181:405-409.
24. Mukherjee, S., M. Feldmesser, and A. Casadevall. 1996. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J. Infect. Dis. 173:1222-1231.
25. Nussbaum, G., W. Cleare, A. Casadevall, M. D. Scharff, and P. Valadon. 1997. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J. Exp. Med. 185:685-697.
26. Pirofski, L., and A. Casadevall. 1996. Antibody immunity to Cryptococcus neoformans: paradigm for antibody immunity to the fungi? Zentbl. Bakteriol. 284:475-495.
27. Pirofski, L., R. Lui, M. DeShaw, A. B. Kressel, and Z. Zhong. 1995. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect. Immun. 63:3005-3014.
28. Rhodes, J. C., L. S. Wicker, and W. Urba. 1980. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect. Immun. 29:494-499.
29. Rivera, J., M. Feldmesser, M. Cammer, and A. Casadevall. 1998. Organdependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect. Immun. 66:5027-5030.
30. Sakaguchi, N. 1993. Ultrastructural study of hepatic granulomas induced by Cryptococcus neoformans by quick-freezing and deep-etching method. Virchows Arch. B Cell Pathol. 64:57-66.
31. Sakaguchi, N., T. Baba, M. Fukuzawa, and S. Ohno. 1993. Ultrastructural study of Cryptococcus neoformans by quick-freezing and deep-etching method. Mycopathologia 121:133-141.
32. Schlagetter, A. M., and T. R. Kozel. 1990. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide. Infect. Immun. 58:1914-1918.
33. Syme, R. M., T. F. Bruno, T. R. Kozel, and C. H. Mody. 1999. The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody. Infect. Immun. 67:4620-4627.
34. Todaro-Luck, F., E. Reiss, R. Cherniak, and L. Kaufman. 1989. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect. Immun. 57:3882-3887.
35. Todaro-Luck, F., E. H. White, E. Reiss, and R. Cherniak. 1989. Immunoelectronmicroscopic characterization of monoclonal antibodies (MAbs) against Cryptococcus neoformans. Mol. Cell. Probes 3:345-361.
36. Valadon, P., G. Nussbaum, L. F. Boyd, D. H. Margulies, and M. D. Scharff. 1996. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J. Mol. Biol. 261:11-22.
37. Vartivarian, S. E., E. J. Anaissie, R. E. Cowart, H. A. Sprigg, M. J. Tingler, and E. S. Jacobson. 1993. Regulation of cryptococcal capsular polysaccharide by iron. J. Infect. Dis. 167:186-190.
38. Vecchiarelli, A., and A. Casadevall. 1998. Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity. Res. Immunol. 149:321-333.
39. Vecchiarelli, A., C. Retini, C. Monari, and A. Casadevall. 1998. Specific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T-cell proliferation. Infect. Immun. 66:1244-1247.